Literature DB >> 28898321

[Cleidocranial dysplasia: a case report].

Olga Medina1, Nelson Muñoz1, Carlos Moneriz2.   

Abstract

INTRODUCTION: Cleidocraneal dysplasia (CCD) is a rare skeletal autosomal dominant syndrome characterized by dental anomalies and bone abnormalities. These clinical manifestations do not require treatment in most cases. The disease is caused by mutation in the gene RUNX2 (CBAF1), located on the short arm of chromosome 6.
OBJECTIVE: To report a case of CCD and perform a literature review focused on clinical manifestations and diagnosis. CASE REPORT: A 3 year old patient, who was clinically diagnosed with CCD since birth. The patient showed incomplete development of cranial bones, bell-shaped thorax, adequate dentition and presence of clavicles. Molecular analysis reported that the patient is carrying the pathogenic variant c.674G>A in the RUNX2 gene, confirming the diagnosis.
CONCLUSIONS: The CCD is a rare condition, with special clinical features. It is important to establish early diagnosis in these patients in order to offer a better quality of life, and if necessary, appropriate treatment.

Entities:  

Mesh:

Year:  2017        PMID: 28898321     DOI: 10.4067/S0370-41062017000400012

Source DB:  PubMed          Journal:  Rev Chil Pediatr        ISSN: 0370-4106


  3 in total

Review 1.  Demographic, clinical, and radiological characteristics of cleidocranial dysplasia: A systematic review of cases reported in south America.

Authors:  Eder Cano-Pérez; Claudio Gómez-Alegría; Fredy Pomares Herrera; Doris Gómez-Camargo; Dacia Malambo-García
Journal:  Ann Med Surg (Lond)       Date:  2022-04-10

2.  Clinical-radiological approach for the diagnosis of cleidocranial dysplasia in adults: A familial cases series.

Authors:  Javier Ignacio Segovia-Fuentes; Jorge Armando Egurrola-Pedraza; Edgar Junior Castro-Mendoza; Eder Cano-Pérez; Doris Esther Gómez-Camargo; Dacia Isabel Malambo-García
Journal:  Clin Case Rep       Date:  2021-12-26

3.  Cleidocranial dysplasia and novel RUNX2 variants: dental, craniofacial, and osseous manifestations.

Authors:  Sermporn Thaweesapphithak; Jirawat Saengsin; Wuttichart Kamolvisit; Thanakorn Theerapanon; Thantrira Porntaveetus; Vorasuk Shotelersuk
Journal:  J Appl Oral Sci       Date:  2022-06-06       Impact factor: 3.144

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.